(Q28266119)

1

0 references

Sara Bristol Calvert

3

0 references

Joao de Andrade

4

0 references

Kevin R Flaherty

5

0 references

Craig Glazer

6

0 references

Robert J Kaner

7

0 references

Mitchell A Olman

American Journal of Respiratory and Critical Care Medicine

8

0 references

language of work or name

English

0 references

publication date

1 July 2012

0 references

published in

0 references

volume

186

0 references

issue

1

0 references

page(s)

88-95

0 references

cites work

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400994

PARticipation in inflammation

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400994

Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400994

Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400994

Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400994

Lung function in idiopathic pulmonary fibrosis--extended analyses of the IFIGENIA trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400994

Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis: a population-based study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400994

Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400994

Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400994

A method to determine the optimal intensity of oral anticoagulant therapy.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400994

A comparison of sample size methods for the logrank statistic

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3400994

Venous thromboembolism and risk of idiopathic interstitial pneumonia: a nationwide study

2 June 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201202-0314OC

Anticoagulant therapy for idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201202-0314OC

A general inefficacy interim monitoring rule for randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201202-0314OC

Steroids in idiopathic pulmonary fibrosis: a prospective assessment of adverse reactions, response to therapy, and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201202-0314OC

Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201202-0314OC

The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22561965

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22561965

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22561965